Drug Database
DT

DTPa+Hep-B+IPV vaccine (Infanrix Penta)

✓ Approved

GSK · 重组蛋白 · 重组蛋白

什么是 DTPa+Hep-B+IPV vaccine?

DTPa+Hep-B+IPV vaccine 是一种重组蛋白,由GSK研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)、Intramuscular (IM) Injection。

药物档案

商品名Infanrix Penta
公司GSK
药物类别重组蛋白, 疫苗
给药途径Injectable (Others), Intramuscular (IM) Injection
状态Approved

治疗适应症

DTPa+Hep-B+IPV vaccine 针对 5 个适应症,涉及 2 个治疗领域。

治疗领域疾病/病症分期
Infections and infestationsDiphtheria✓ Approved
Infections and infestationsHepatitis B✓ Approved
Infections and infestationsPertussis✓ Approved
Infections and infestationsTetanus✓ Approved
Surgical and medical proceduresPolio immunisation✓ Approved

相关研究文献

PubMedInternational journal of women's health2026-11-18

Health Decision-Making Among Women Survivors of Intimate Partner Violence: A Scoping Review.

Lee Jiae J, Kim Yoonjung Y, Kim Eunjin E

Intimate partner violence (IPV) affects approximately one in four women worldwide, with profound consequences for physical, mental, and reproductive health. Autonomy in health decision-making is central to women's health, yet IPV undermines survivors' capacity to make free and informed choices about their own care. A comprehensive synthesis of the barriers and supporting factors to this autonomy is still lacking. Such understanding is essential for equipping healthcare providers with the evidence needed to recognize abuse, respond effectively, and support affected women. This scoping review followed Arksey and O'Malley's five-stage framework and the PRISMA-ScR guidelines. PubMed, CINAHL, PsycINFO, and Scopus were searched in May 2023, with an update in October 2026. Studies were eligible if they examined health decision-making in relation to IPV, including associated sociodemographic and contextual factors, among women survivors, with no restrictions on publication date or study design. The 23 included studies were conducted in South Asia (n = 7), the United States (n = 7), Sub-Saharan Africa (n = 3), Australia (n = 2), the United Kingdom (n = 2), East Asia (n = 1), and the Middle East (n = 1), with an aggregate population of 192,532 participants. Three overlapping domains were identified: reproductive and maternal health decisions (n = 7), healthcare-seeking and disclosure decisions (n = 12), and safety and support-seeking decisions (n = 11). Key barriers included fear of retaliation, stigma, financial dependence, low educational attainment, patriarchal control, reproductive coercion, limited knowledge of resources, and unresponsive healthcare encounters, whereas facilitators included empathic and confidential provider engagement, knowledge of rights, personal resilience, and support from family, friends, and formal services. Health decision-making among IPV survivors was shaped by intersecting individual, structural, and healthcare-system factors that varied across contexts, suggesting the need for integrated, context-sensitive responses beyond individual-level approaches.

PMID 43048146
阅读全文 →
PubMedBioinformatics and biology insights2026-11-18

Formulation of a Novel NS5A- and NS5B-Based Chimeric Vaccine Against Hepatitis C Virus: An Artificial Intelligence-Supported Approach.

Niknam Maryam M, Zohrabzadeh Maryam M, Hahashempour Ava A, Honari Jahromi Ali A et al.

We aimed to design a multiepitope vaccine against hepatitis C virus (HCV) with the potential to elicit broad protective immunity against diverse HCV genotypes through computational design.Method: One hundred sequences of the most widespread subtypes of HCV were retrieved from the Los Alamos National Laboratory database, and consensus sequences of the NS5A and NS5B proteins were generated to construct an efficient vaccine for human use. Numerous B-cell lymphocyte, cytotoxic T-lymphocyte and helper T-lymphocyte epitopes located in the conserved domains of HCV proteins and similar in human and mouse alleles were evaluated criteria for use in the vaccine construct. Population coverage analysis identified that substantial parts of the worldwide population carry epitopes and their corresponding alleles within their genome, which confirms that the vaccine candidate is an effective agent against this lethal disease. Codon optimization and in silico cloning of eukaryotic and prokaryotic vectors validated the strong expression of the vaccine construct in the host systems. Molecular docking analysis revealed favorable binding affinities between the vaccine construct and toll-like receptors, which confirmed the vaccine's capacity to induce robust and stable immune responses against the hepatitis C virus. We incorporated new bioinformatic methods to design multiepitope vaccine against HCV. The development of a vaccine targeting multi genotypes of HCV could potentially provide for long-term protection against infection and may mitigate the risk of drug resistance across various genotypes and subtypes. Current research emphasizes the need for a vaccine that can elicit comprehensive immune responses, including both neutralizing antibodies and T-cell responses, to effectively address the genetic diversity of the virus. Future experimental studies are essential to validate predicted immunogenicity, structural stability, and protective efficacy before clinical consideration.

PMID 43047676
阅读全文 →
PubMedJournal of nanobiotechnology2026-11-18

Baculovirus-based production of virus-like particles for avian influenza: development, immunogenicity, and cross-protection against H5 and H7 AIVs.

He Yanjuan Y, Dong Yajing Y, Kong Dexin D, Chen Huixin H et al.

The persistent threat of H5 and H7 highly pathogenic avian influenza (HPAI) necessitates effective broad-spectrum vaccines. This study systematically evaluated the immunogenicity and protective efficacy of H5N6 virus-like particle (H5N6-VLP) vaccine and subsequently developed a trivalent VLP vaccine (H5N6-H5N8-H7N9-VLP) using the baculovirus expression system (BEVS). Production of H5N6-VLP was optimized at a multiplicity of infection (MOI) of 0.1 to achieve efficient assembly. The H5N6-VLP vaccine induced potent immune responses in specific-pathogen-free (SPF) chickens, providing 100% protection against homologous H5N6-GD154 virus when the HA titer reached 9 log2. Compared with traditional inactivated vaccines, the H5N6-VLP vaccine induced faster humoral immune responses and higher CD8⁺ T cell proportions. The HI seroconversion rate was 30% on day 7 post-immunization (0% for inactivated vaccine), reached 100% by day 10, while it was only 80% on day 14 for the inactivated vaccine. Furthermore, the protective efficacy of the H5N6-VLP vaccine was associated with increased IFN‑γ expression and elevated proportions of B cells and CD8⁺ T cells. Although both vaccines provided complete homologous protection, the H5N6-VLP vaccine showed better cross-protection against the heterologous H5N1-D889 strain (70% vs. 40%). A delayed challenge experiment further demonstrated that the H5N6-VLP vaccine induced durable immunity, with HI titers remaining above the protective threshold and 100% protection against homologous challenge at 8 weeks post-immunization. Based on these findings, a trivalent H5N6-H5N8-H7N9-VLP vaccine was developed. The trivalent vaccine induced substantial antibody responses and provided complete protection against parental and circulating strains, with efficacy comparable to a commercial inactivated vaccine and no detectable antigenic interference between components. Our findings highlight the potential of the BEVS-derived H5N6-VLP vaccine, particularly its early antibody induction, which allows rapid flock protection during acute HPAI outbreaks, and its cross-reactivity against heterologous strains. Furthermore, the trivalent vaccine formulation extends the potential application of this VLP platform for broad-spectrum HPAI control.

PMID 43046102
阅读全文 →
PubMedBMC genomics2026-11-18

Genomic characterization and immunoinformatics analysis of the Brucella melitensis vaccine strain BA0711.

Zhang Mengqi M, Cheng Yiwen Y, Yin Zhenghang Z, Niu Shihua S et al.

B. melitensis BA0711 is a novel genetically engineered attenuated live vaccine strain constructed by the targeted deletion of the cold shock protein A (CspA) gene. While previous studies demonstrated its safety and protective efficacy in animals, its underlying comparative genomic characteristics, pathogenicity evolution, and theoretically predicted immunogenic potential from a genome-wide perspective remain to be systematically elucidated. In this study, a high-quality complete genome of B. melitensis BA0711 was obtained using a hybrid next-generation sequencing and third-generation sequencing strategy. The genome comprised two closed circular chromosomes totaling 3,310,449 bp, with no plasmids or exogenously acquired antimicrobial resistance genes detected. Phylogenetic, multilocus sequence typing, and whole-genome similarity analyses determined B. melitensis BA0711 as the ST8 lineage and revealed its closest genetic relationship with B. melitensis M28 among the reference strains analyzed. Whole-genome collinearity and pangenome analyses further revealed a highly conserved genomic backbone and macro-syntenic organization. Horizontal gene transfer analysis identified 263 putative horizontally transferred genes, including a pathogenicity-associated genomic island, GI_6, containing multiple core lipopolysaccharide biosynthesis and modification genes. Comparative profiling of core virulence factors confirmed the targeted absence of cspA and revealed lineage-associated amino-acid variation in several virulence-related proteins. Following host-homology screening, immunoinformatics analysis of 78 core virulence-associated proteins retained 5,212 non-host-homologous MHC-I strong-binding epitope records, 7,476 non-host-homologous MHC-II strong-binding epitope records, and 574 non-host-homologous linear B-cell epitope candidates. Cgs and BPE043 were prioritized as representative T-cell epitope-rich proteins. Sequential screening based on antigenicity, allergenicity, toxicity, and HLA-binding breadth further identified four representative peptides: SSAAISSAF, LSMFVAPTF, SLNSLSVDIARAIDH, and RRFIRQLPLYKVPLE. AlphaFold 3 modeling and complementary HPEPDOCK analysis supported structurally plausible presentation of these peptides within the corresponding canonical HLA-binding grooves. The targeted deletion of cspA was additionally confirmed by PCR. Our whole-genome comparative analysis elucidates the genomic architecture and evolutionary background of B. melitensis BA0711. The strain possesses a conserved ST8-associated genomic background and shows the closest genetic relationship with B. melitensis M28 among the analyzed reference strains. Systematic profiling of genome organization, putative horizontally transferred genes, and virulence-factor variation provides a molecular framework for understanding this vaccine strain. Moreover, immunoinformatics analysis prioritized Cgs and BPE043 as representative T-cell epitope-rich proteins and identified four peptide candidates with computationally plausible HLA-presentation modes. These in silico findings identify experimentally testable candidates for further investigation but require experimental validation of HLA binding and immunogenicity.

PMID 43046134
阅读全文 →
PubMedAdvanced materials (Deerfield Beach, Fla.)2026-11-18

Intracellular Bacterial Imprinting Enables Preservable Whole-Cell Vaccination.

Liu Xing X, Lu Zhenyu Z, Wang Weixiu W, Zhang Daining D et al.

Whole-tumor-cell vaccines preserve broad tumor-antigen repertoires, but converting living tumor cells into safe and intrinsically immunogenic vaccine substrates remains challenging. Here we generated bacteria-imprinted tumor (BiT) cells through the controlled internalization of attenuated Salmonella and subsequently prepared them as nonproliferative cellular vaccines by freeze-drying. Within a defined bacterial-loading window, intracellular Salmonella induced endoplasmic reticulum stress-associated immunogenic preprogramming while preserving tumor-cell integrity, thereby enhancing danger-signal exposure, antigen-presentation capacity, and immune visibility. Freeze-drying preserved the bacteria-induced immunogenic imprint by retaining key molecular and functional attributes while maintaining overall cellular architecture and markedly reducing residual bacterial viability. Vaccination with freeze-dried BiT (FD-BiT) cells elicited coordinated innate and adaptive immune responses, including antigen-presenting cell activation, T follicular helper-B-cell cooperation, and germinal-center formation. This coordinated T-B cell response was accompanied by durable memory formation and enhanced intratumoral CD8+ T-cell infiltration, proliferation, and functional maintenance. Accordingly, FD-BiT reduced primary tumor establishment and pulmonary metastasis and restrained the growth of tumors that emerged despite prophylactic vaccination. These findings establish intracellular bacterial programming and freeze-drying-mediated imprint preservation as a cell-engineering principle for whole-tumor-cell vaccination.

PMID 43046763
阅读全文 →
PubMedWomen's health reports (New Rochelle, N.Y.)2026-11-18

Postpartum HPV vaccination uptake: attitudes, beliefs, and determinants of acceptance.

Currier Jessica J JJ, Gagliuso Amelia H AH, Myers Emily E, Nguyen Christine Gt CG et al.

High-risk human Papillomavirus (hrHPV) is associated with six cancers. Although vaccination rates in the United States are increasing, series completion remains below the Healthy People 2030 goal of 80%. Pregnant individuals are a population with low HPV vaccination coverage, with only 7.5%-15.5% of patients aged 18-26 years receiving HPV vaccination prior to delivery. The postpartum period represents an opportunity to initiate or complete the HPV vaccination series. This study examined knowledge, attitudes, and beliefs regarding HPV vaccination among previously unvaccinated postpartum individuals and compared perspectives between those who accepted and declined vaccination. Postpartum individuals aged 18-26 were offered HPV vaccination. Participants completed a survey and semi-structured interviews. Patient characteristics, including HPV knowledge, were compared between participants who accepted and declined vaccination. Qualitative thematic analysis identified factors influencing vaccine attitudes and beliefs. Among participants, 53% accepted HPV vaccination and 46% declined. HPV knowledge was lower among participants who accepted the vaccine compared to those who declined; although this difference was not statistically significant. Vaccine hesitancy was associated with concerns regarding safety, effectiveness, and the need for additional information. Qualitative findings indicated that belief in the vaccine's cancer prevention benefits facilitated vaccine acceptance. Frequent healthcare encounters during the perinatal period created opportunities for provider counseling and vaccine delivery. The perinatal period offers a critical opportunity to promote HPV vaccination through frequent health care encounters and opportunities for ongoing education. However, access alone may be insufficient to optimize vaccine uptake. Vaccine hesitancy remained a significant barrier, and the immediate postpartum period was not consistently perceived as an optimal time for vaccination among some individuals experiencing heightened stress or competing medical priorities. Strategies to increase postpartum HPV vaccination should prioritize strong provider recommendations, clear communication about the vaccine's cancer prevention benefits, and interventions that addres vaccine hesitancy and structural barriers to vaccination.

PMID 43048345
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多DTPa+Hep-B+IPV vaccine